The Effect of Home Exercise Programs Applied of Congenital Muscular Torticollis.
Launched by GAZI UNIVERSITY · Jan 17, 2024
Trial Information
Current as of March 11, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effectiveness of home exercise programs for babies with congenital muscular torticollis (CMT), a condition that affects the neck and head position of infants. CMT can make it difficult for babies to turn their heads and can lead to other issues if not treated. The goal of the trial is to see how well a structured exercise program, done at home with family support, can help improve the condition. Families will receive guidance and education on how to carry out the exercises, which is intended to make treatment more convenient and effective.
To participate in this study, babies must be between 0 to 12 months old and diagnosed with CMT by a doctor. Families need to be willing to join the exercise program. However, babies with certain neurological issues, sensory impairments, or those who have previously received treatment for CMT will not be eligible. If families choose to participate, they can expect to play an active role in their baby's treatment and work closely with researchers to help improve their child's condition. This trial is currently recruiting participants, and being involved could provide valuable support and resources for families dealing with CMT.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Babies aged 0-12 months with a diagnosis of congenital muscular torticollis (CMT)
- • Families who agree to participate in the study will be included in the exercise program
- Exclusion Criteria:
- • Those who have any neurological risk factors were included in the study,
- • Those who are affected by their visual/hearing senses,
- • Those who have not been diagnosed with Congenital muscular torticollis (CMT) by a doctor,
- • Those who have previously received treatment for the diagnosis of CMT,
- • Babies with a history of BOTOX-A/surgery applied to the Sternocleidomastoid (SKM) muscle before treatment will not be included.
Trial Officials
Sinem ERTURAN
Principal Investigator
Study Principal Investigator
About Gazi University
Gazi University, a leading research institution based in Ankara, Turkey, is committed to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university integrates cutting-edge research with clinical practice to explore new therapeutic approaches and enhance existing treatments. Gazi University adheres to the highest ethical standards and regulatory guidelines, ensuring the integrity and safety of its clinical trials. By fostering partnerships with healthcare professionals and academic institutions, Gazi University aims to contribute significantly to the global scientific community and address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0